Professional Documents
Culture Documents
Jurnal Teori Kep Dan Anest PDF
Jurnal Teori Kep Dan Anest PDF
nurse anesthesia
SUSAN A. MARTIN, CRNA, MSN
Destin, Florida
anesthsia
.*
su A *er=
DIPRIAN/DIPRIAN tehiu v
DIRVNDPIA te0chnique
DIPRIVAN~~~~~~~~~~
upr rwho
ca0tl irognssa ti o
an ~ rsre 0niirbal
rd c
For nducion
hrogh minteance1_7
0PR
DIPRIVANA
DIPRIVAN"(propofol)InjectableEmlaion wuvirniv (prpuiuj tlwcjUei* wmus ion
EMULSION
INJECTABLE FORIVADMNISTRAION SUMMARY
BRIEF (or PullPrescribing SeePackage
Information, Insert) effectsof DIPRIVAN Injectable Emulsion. DIPRIVAN Injectable Emulsion doesrot causea clinically significantchange in onset
-UDICATIUSA
ADUSAGE intensity,or durationofactionof thecommonly usedneuromuscular leg,
bloclog agents succinytchotise aodnondepotaring
DIPRr/AN Injectable is
EmulsionanIVsedative-hypnoic agent thatcanbeused
in
for bothinduction and/or maintenance of anesthesia musclerelaxants). Nosignificatadverse interactionswithcommonly usedpremedications or drugsusedduringanesthesia or
as partof a balanced anesthetic technique forinpatientandoutpatient surgery adultsandin children 3 yearsof ageor older sedation(indudinga rangeof musclerelaxants,
beenoberved
inhatational agents,analgesic agents,andlocal anesthetic agents)have
DIPfVANInjectable Emulsion, whenadministered intravenously us directed, car be usedto initiateandmaintain monitored
anesthesia care(MAC) sedation duringdiagnostic in
prcedures adults. DIPRRIAN Injectable Emulsonmayalsobeusedfor MAC
DIPRIRN nCerciuegeuss,
vitroand vvo animal
Mutugmeses, Imparuaen of FertWlfAnimal
testsfailedto showanypotential
carcinogenicity
for mutagesicity
studies have
ty propofofTents
not been performed
for mutagesicity
with
incfuded
propofol.
theAmes
In
sedation inconjunction withlecaregioeal anesthesia anpatients undergoing surgicalprocedures. (SeePRECAUTIONS.)
Injectable Emulsion should onlybeadministered tointubated,mechanically ventilated adultpatients intheIntensive CareUnit(ICU) (usingSamonela sp)mutation testgenemutation/gene conversion usingSaccharomyces erievnine, invitrocytsgeneic studies
to providecotinuoussedationandcontrolof stressresponses In thls setting,DIPRMNInjectabeEmulsion shouldbe in Chinese hamsters, anda mouse micronucleus test Studes infemaleratsatintravenous dosesup to15mg/hg/day (6 tmesthe
administered onlybypersons skilled inthemedicalmanagement ofcritically ill patients n
andtrained cardiovascular resuscitation maximumrecommended human inductiondose) for2 weeksbefore pregnacy today7 ofgestation didnotshowimpared fertility.
andairway manageeent DIPRANInjectable Emulsonisnot recommended for obstetrics, incldig cesarean section deliveries. Male fertilityinratswannotaffected ina dominant lethalstudyatintravenous dosesupto 15mg/ltglday for5 days
DIPRNAN Injectable ion
Emu crosses theplacetta, anduswithothergeneral anesthetic agents,theadministration of DIPRNAN Pregany Category B:Reproductior studies havebeenperformed inratsandrabbits at intravenous dosesof15 mg/kg/day (i
Injectable
recommended
Emulsion maybeassociated
foruseinnursingmothers
andtheeffectsoforalabsorption of small
wieth neonatal
because
amounts
depression
DIPRtrAN
of propofol
(See
Injectable
PRECAUTIONS.)
Emulsion
DIPRIN
has beenreported
arenotkown (SeePRECAUTIONS)
in
Injectable Emlson
to beexcreted humanmlk
DIPRONN Injectable
is not
Emulsion
times the
propofol.
recommended
Ropfol, however,
lactatingperiodin damstreated
human induction dose) and
has beenshownto causematemal
with15 mg/kg/day
have revealed no
deaths
nvidencn ofimpaired fertility
inratsandrabbitsanddecreased
(or6 timestherecommended humaninduction
or harm to the fntus dueto
pupsurvivalduringthe
dose).Thepharmacological
is notrecommended foranesthesia anchildren below theageof3 yearsbecause safetyandeffectiveness haverot beenestablished. activity(anesthesia) is
of thedrugonthemother probably responsible for theadverse effects seenintheoffspring. Thereare,
DIPRIVAN Injectable Emulsion hr ootrecommended in
for MACsedation children because safetyandeffectiveness have not been however, noadequate andwell-controlled studies in pregnant women. Becuse animalreproduction studes arenotalways predictive
estabshed. DIPRIVAN Injectable is
Emulsion notrecommended for pediatric ICUsedation because safetyandeffectiveness have ofhumanresponses, thisdrugshouldbeusedduringpregnacy onlyifclearlyneeded.
notbeenestablished. LakranDueBe: DIPRIVAN InjectableEmulsion is notrecommended for obstetrics, including cesarean sectiondeiveries
CONTRAINDICATIONS DIPRJAN Injectable Emulsion crosses theplacenta, anduswithothergeneral anesthetic agents,theadminitration of DIPRRPPN
DIPRtANInjectable is
Emulsion contraindicated inpatients witha knownhypersensitivity to DIPRIRN Injectable Emulsion orits Emulsion maybeassociated withneonatal depression.
components, orwhengeneral anesthesia orsedation arecontraindicated NusingMntern: DIPRIVAN Injectable Emulsion is notrecommended for usein nursingmothers because DIPRIVAN Injectable
Forgeneral aneslheaerInernd aestelaa eat(MAC) sedaion, DIRIIIN Injetae EulIonIbSd beadiebdalered Emulsion
not known.
has beenreported to be ecretedin humanmilk,andtheeffects of oralabsorption ofsmallamounts of propofol are
mauageme.Intfo
effectiveness
fatalities)
inchildren
havenotbeenestablished.
havebeenrepoited
withrespiratory
inchildren
Althongh
givenDIPRIVAN
tract infections
nocausalrelationship
Injectable
givendosesinexcess
Emulsion
hasbeenestablished,
for ICUsedation.
ofthoserecommended
senous
Thnse
foradults.
adverseevents
events
(including
wereseenmostoften
shouldrotbe coadministered
maintenanc
These
in
cardiorespiratory
boluses,
through
effectsamrelicelyto occur
especialytheelderlydebilitated,
the same (Vcatheter withblood
orASA
or pasma
andvarious otheranestheticlsedative
AesdhesutaudMAC
fromcliicaltrialsingeneral
Aduk:
Seda inu
agents.
anesthesia/MAC
Mostadverse
Thefollowing
sedation (N=2889
events weremildandtransient
estimatesofadverse
adultpatents).
eventsforDIPRrANInjectable
Theadverse eventslistedbelow
Emulsion include
as probably
data
causally
because compatibility hasnotbeen established. Invitrotestshave shownthataggrngates oftheglobuhr component of theemulsion relatedarethoseevents inwhichtheactualincidenco rateinpatients treated withDIPRIVAN Injectable Emulsion wangreater than
vehicle haveuccurred withblod/plusma/serum fromhumans andanimals. significance
clinical
The is notknown the comparatur incidenco rateinthesetrials.Therefore, incidence ratesfur anesthesia andMACsedation in adultsgeerally
STRICT ASEPTIC TECIMOUE MUST AlWAYS BEMAINTAINED DURING HANDLING. DIPRIVAN INJECTABLE EMULSION IS A represent estimates of thepercentage of clinicaltrialpatients whchappeared to haveprobable causalreationship.Theadverse
SIGLE-USE PARENTERAL PRODUCT WHICH CONTAIS D.NS%DSODII EDEITETORETARD RATE THE OFGROWTH OF expeienceprofile tromreports
during
of150patients inthe MACsedation
anesthesia(seebelw). During
clinical
MACsedation
trialsis simiiartotheprofileestablished
clinicaltrials, sgnificant respiratory
withDIPRVi
eventsincluded cough,
MICROORGAISS INTHEEVENTOFACCIDEITAL EXTRINSIC COTANINATION. HOWEVER, DIPRIVAN IUEC1RILEEMULSION InjectableEmulsion
CANSTILL SUPPORT THEGROWTH OFMICROORGANSNS ASIlS NOT ANANTIMICROIALy PRESERVED PRODUCT UNDER upperairwayobstruction, apne,hypoventilahon, anddyspnea.
USPSTANOARDS. ACCORDINGLY, STRICT ASEPTIC TECHNIQUE MUST STILL BEADHERED TO.DONOTUSE IFCONTMINATION Anesthesla InChildree:Generally the adverse expeence profilefromrepoitsof 349DIPRIVAN Injectable Emulsion pediatric
IS SUSPECTED. DISCARD UNUSED PORTIONS ASDIRECTED WITHIN TlE REQIREDTIMEUNITS(SEEDOSAGE AND patients behween the agesof 3and 12yearsintheUS/Canadan anesthesia clinicaltrialsis similartotheprofile established with
ADMINISTRATION, HANDUIIG PROCEDURES). THERE HAEBEEN REPORTS U WHICH FAILURE TOUSEASEPTIC TECHINIUE DIPRIVAN Injectable Emulsion duringanesthesia inadults (seePediatric percentages [Peds%]below).Although notrepoted asan
WHEN HANDIGDINRIVAN NUIECTANLE EMULSION WAS ASSOCIATED WITHMICROBAL COITANINATION OTHEPRODUCT adverse eventinclinicaltrials,apnea isfrequently obseredin pediatric patients.
ANDWITHFEVER, IFECTION/SEPSIS, OTHER LIFE-THREATENING ILNESS,AND/OR DEATH. ICUSedaton inA lts:Thefollwingestimates of adverse eventsinclude data fromclnicaltrialsinICUsedation (N=159) patients.
PRECAUTIONS General: A lwer induction doseanda slowermaintenance rateof administration should be usedin eldedy, Probably relatedincidencoratesfor ICUsedation weredetermined by individual casereportformrevlew. Probable causality wan
debilitated, orASAIIUIV patients. (SeeCLINICAL PHARMACOLOGY- Individualzation of Dosage) Patients shouldbecontinuously baseduponanapparent doseresponsereationshipand/orpositive responsesnorechallenge. In manyinstances thepresence of
monitored foready sigs of significant hypotension and/orbradycardia. Treatment
or administration
mayinclude
of atropine. Apnea
increasing the rateofintraveous
induction
oftenoccursduring and
concomitant
generally
dlsease
represent
and concomitant
estimates
therapy
oftheperentage
made the causal relationship
ofclinicaltrialpatients
unknown.
whichappeared
Therefore, incidenco
to havea probable
rates forICU sedation
causalrelationship.
uid,elevation oflwer extemiies,useof pressor agents,
maypersist formorethan 60 seconds. Ventilatory support maybe required. Because DIPR/ANInjectable Emulsion isan emulsion,
cautionshouldbe exercised in patients withdsordersof lipid metabolism suchan primaryhyperlipoproteanemia, diabetic
bypedipemia, andpancreatitls. Theclinical criteriafor dischargefromtherecovery/day surgery ores established foreachistitution
shouldbesatisfiedbeforedischarge ofthe patient fromthecareof6w anesthespsiol t WhenDIPRIUN is
Injectable Emulsion Incidence greater tan 1%-ProbayCasallyRelated Cardiavascutar Edema,
(continued)
Etrasystole, Vntricuar
HeartBlock, Tachycardia
administered toanepileptic patientwthere maybea riskofseizure during.nrecoveryphase.adults andchildren, attentionshould
bepaidtominimize pain on adminrtration of DIPRtAN Injectable Emulsion. local
Trnsent minimized
pan canbe ifthe larger veins Hypertension,
oftheforearmorantecubital fossa areusedPainduring intravenous injecton mayalso bereduced byprorinjectionofIVlidocane Myocardial Infarction,
Sedation ICU Sedation MyocrdialIchomia,
(1mltofa 1%solution). Painor injection occurred frequently inpediatric patients (45%)whenasmallveinofthehandwasutilized Cardiovascuiar Bradycardia Bradycordia,
withoutlidocainepretreatment. Withlidocalne pretreatment or whenantecubital veins wereutilized, pan wanminimal(incidence Hyoeso' Decreased
Premature Vntricuiar
lessthan10%)andwelltolerated.Venous sequelae (phetis orthrombosis) nave beenreported rarely(<1%).Intwowell-controlled Contractions, ST
Pd:17%/] Cardiac Output,
SHypertension SegmentDepression,
cliical studies usingdedicated
inductionIntraartenal
patients,
injection
intravenous
in animals
and,otherthanpain,therewerenomajorsequelae.
cathetrs,
didnotinduce
no intancesof venous
localtissueeffectsAccidental
Intentional
sequelae wereobserved
injection
itra-aiterial
injectionintosubcutaneous
up to 14daysfollowing
hanbeenreported
onperivascular tissuesof
in %
Pnds:8%
(seealsoCLINICAL
Hpotension
Supraventricular
Tachycardia, Tchycardia,
animalscausedminimal tissuereaction. During the potmadetingperiod, therehavebeenrarereports of lecalpain,swelling, PHARMACOLOGY) Ventricuiar Fibrillation
blisters,and/or tissuenecrosis folowig accidental eoravasatios ofDIPRIVAN Injectable Emulsion. Pan operativemyoclonia, rarely CentralNervous Central Nerous
including conlsionsandopisthotonos, has occurred intemporal relationship incanes inwhichDIPRPAN Injectable Emulsion han Movement[Peds 17%) System Abnormal Dreams, Chills/Shivering,
System: Amorous Intracranial
beenadministered. Clinical features of anaphytuos, whichmayinclde angioedema, broechospasm, erythema, andhypatension, Site: Buming/Stinging Agitation,
Injection
occur raNlyfollowingDIPRIVAN Injectable Emulsion administration, althogh useof otherdrugs in mostinstances makes the Behavior, Anxiety, Hypertension,
or Pan,17.6% BcigJri Seus,
relationship toDIPRPAN Injectable Emulsion unclearThere havebeerrarerepotsof pulmonary edemaintemporal relationship to (Pods. 1(1%) g Chil
Thrashing, Somnolence,
the administration ofDIPRIVAN Injectable Emulsion, although a causal relationship is unknown. DIPRIVAN Injectable Emulsion han Metaholic/Nutritional: Hyperipomia'
no vagoyticactivity. Reports of bradycardia, anysole, rarely,
and cardiac arresthavebeenassociated withDIPRPJAN Injectable Respiratory: Anes Respiratory Shivering,
Myoclonic
Clonic/
Movement,
Thinking
Abnormal
Emulsion. Theintravenos administation ofantcholinergic agents (og,atropine orgycopynolale) should be considered to modify (seealsoCLINICALAcidosis
potential increaesan vagaltone dueto concomitant agents (a, succanyichotine) orsurgicalstimuli. PHARMACOLOGY) During Combativeness,
leeinleCregeHSedaiOn: ad DOAGEANDAMINISTRATION, Handling Prtcedre.)Theadministration Confusion, Delirium,
(SeeWARNIMGS Weaning* Depression, Dziness,
(>5
of DIPRIVAN Injectable
min)inorderto minimize
Dosage.) Patients
Emulsion
shouldbemonitored
shouldbeiitiatedasacontinuous
hypotension andavoidacuteaverdosage.
for earlysigns of ugniffantl
infusionandchanges
i'V
(SeeCLINICAL
inthe rateofadministration
PhARMACOLOGY
and/orcardiovascuar depression,
madeslowly
- Individualiation
whichmaybe
of
Skinand
Appendages: Rush [Peds: 5%] Emotional
Euhoria,
Lability,
Fatigue,
profound.Theseeffectsare responsive to discontinuation of DIPRN Injectable Emulsion,/ ffuid administration, and/or Eventswithoutan'or % hadanincidence of1%-3% Hallucinations,
vasopressortherapyAs withothersedative medications, thereis wideinterpatient variabilrty inDIPRPVAN Injectable Emulsion Incidenceofevents3%to10% Headache, Hypotonia,
dosagerequirements, andtheserequirements maychangewithtime.Failureto reducethe infusionratein patentsreceiving Hysteria, Insomnia,
DIPR VANInjectable Emulsion forextendedperiodsmayresuRinexcessively high blondconcentrations of the drug.Thus, titration Moaning, Neuropathy,
Incideeseless thn 1%-ProbabhCausally Related
toclinical responseanddailyevaluation of sedation levels areimportantduringuseof DIPRIUAN Injectable Emulsion infusionfor Opisthotonos,
Seizures,
Rigidity,
Somnolence,
CU sedation, especiayoflog duration. Opioids andparalytic agents shouldbedicontinued andrespiratoryfunction optimized
proto wens patients trammechanical vestitation. Infusions ofDIPRraAN ljectable Emubson shouts beadjusted tomaintain a Anesthesia/MAC Tremor,Twitching
level
right ofsedation priortoweaning pahientu froes mechanical vesidatory support. Thmnughoid twweaning processthhr level of Sedation ICU Sedation Digestive: Cramping, Diarrhea, linus,Liver
sedation maybe maintained in theabsence of respiratory depression. Because of the rapidclearance of DIPRIVAN Injectable Bodyas a Whole. Anaphyaxis/ DryMouth,Eniarged Function
abruptdiscontinuation of a patient's infusionmayresultin rapidawaeningofthe patientwithassociated anxiety, Anaphylactoid Parotid,Nausea, Abnormal
Emulsion,
agitation,and resistanceto mechanical ventilation, making weaningfrom mechanical ventiationdificult. I is therefore Reaction, Swallowing, Vomiting
recommended thatudministration of DIPRIVAN Injectable Emulsion be continued in orderto maintain a tightlevelof sedation Perinatal Disorder Hematolugic/
throughout the weaning process until10-15 minutes priorto extubationat whichtimethe infusion canbe discontinued. Since Cardiovacuar Premature Atrial Lymphatic: Coaguation Disorder,
DIPRIANInjectable Emulsionasformulated in an oil-is-water emulsion,elevations in serumtriglycerides mayoccurwhen Contractions, Leukocytssis
DIPRIVAN InjectableEmulsion is administered forextendedperiodsoftime.Patients atriskof hyperiipldemia shouldbemonitored Syncope Injection Site: Hives/ltching, Phlebitis,
for increaesis serum triglycerides orserumtudidty.Administration of DIPRIVAN InjectableEmulsion shouldbeadusted if fatis Central Nerous Redness/Discoloration
beingloadequately cleared fromthebody.Aredaction inthe quatityofcoecurrntlyadministeredlipids isindicated tocompensate System: iypertonialDystoria,
Paresthesia Agitation
Metabolic/
Nutritional: Hyperkalemia, BUNIncreased,
fortheamount of lipidinfused anpartofthe DIPRIVAN Injectable Emulsion formulation; 1 rt of DIPRIVAN Injectable Emulsion